AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 36 filers reported holding AQUESTIVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 2.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $199,000 | -7.9% | 130,305 | 0.0% | 0.00% | – |
| Q2 2023 | $216,000 | +45.9% | 130,305 | 0.0% | 0.00% | – |
| Q1 2023 | $148,000 | +26.5% | 130,305 | 0.0% | 0.00% | – |
| Q4 2022 | $117,000 | -23.0% | 130,305 | 0.0% | 0.00% | – |
| Q3 2022 | $152,000 | -55.3% | 130,305 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $340,000 | -32.1% | 130,305 | +1.2% | 0.00% | 0.0% |
| Q4 2021 | $501,000 | -9.4% | 128,805 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $553,000 | +9.7% | 126,805 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $504,000 | +41.2% | 126,805 | +84.8% | 0.00% | 0.0% |
| Q1 2021 | $357,000 | – | 68,617 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 9,810,958 | $16,188,081 | 100.00% |
| Vahanian & Associates Financial Planning Inc. | 725,208 | $1,196,593 | 3.78% |
| Bracebridge Capital, LLC | 428,571 | $707,142 | 0.39% |
| Latash Investments, LLC | 243,134 | $401,171 | 0.32% |
| XTX Topco Ltd | 138,145 | $227,939 | 0.04% |
| ARMISTICE CAPITAL, LLC | 1,158,000 | $1,910,700 | 0.03% |
| OCCUDO QUANTITATIVE STRATEGIES LP | 84,355 | $139,186 | 0.01% |
| Hillsdale Investment Management Inc. | 66,600 | $109,890 | 0.01% |
| D.B. Root & Company, LLC | 12,950 | $21,368 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 147,856 | $243,962 | 0.01% |